A Clinical Study to Explore the Safety and Efficacy of CT0991 in Relapsed/ Refractory Acute Myeloid Leukemia
Clinical trial NCT07233018 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07233018
- Sponsor
- MEI HENG
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-18
- Primary completion
- 2026-06-30
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.